Abstract:Background: Parkinson's disease (PD), the most common neurodegenerative disorder, primarily affects dopaminergic neurons in the substantia nigra (SN). In addition to severe motor dysfunction, PD patients appear apparent cognitive impairments in the late stage. Cognitive dysfunction is accompanied by synaptic transmission damage in the hippocampus. Cordycepin has been reported to alleviate cognitive impairments in neurodegenerative diseases. Purpose: The study aimed to estimate the protection roles of cordycepin on cognitive dysfunction in PD model and explore the potential mechanisms. Methods: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was used to establish the PD model in vivo and in vitro experiments. In the in vivo experiments, the C57BL / 6 mice were intraperitoneally injected with MPTP and intragastric administration with cordycepin. Open field test (OFT) was used to estimate the exercise ability. Spontaneous alternation behavioral (SAB) and morris water maze (MWM) tests were used to evaluate the learning and memory abilities. The hippocampal slices from C57BL / 6 and Kunming mice in the in vitro experiments were used to record field excitatory postsynaptic potential (fEPSP) by electrophysiological methods. Western blotting was used to examine the level of tyrosine hydroxylase (TH) in the in vivo experiments and the levels of adenosine A(1) and A(2A) receptors (A(1)R and A(2A)R) in the in vitro experiments, respectively. The drugs of MPTP, cordycepin, DPCPX and SCH58261 were perfused through dissolving in artificial cerebrospinal fluid. Results: Cordycepin could significantly reduce the impairments on motor, exploration, spatial learning and memory induce by MPTP. MPTP reduced the amplitude of LTP in hippocampal CA1 area but cordycepin could improve LTP amplitudes. Cordycepin at dosage of 20 mg/kg also increased the TH level in SN. In the in vitro experiments, MPTP inhibited synaptic transmission in hippocampal Schaffer-CA1 pathway with a dose-dependent relationship, while cordycepin could reverse the inhibition of synaptic transmission. Furthermore, the roles of cordycepin on synaptic transmission could been attenuated in the presence of the antagonists of A(1)R and A(2A)R, DPCPX and SCH58261, respectively. Interestingly, the level of A(2A)R rather than A(1)R in hippocampus was significantly decreased in the cordycepin group as compared to the control. Conclusion: The present study has showed that cordycepin could improve cognitive function in the PD model induced by MPTP through regulating the adenosine A(2A) receptors. These findings were helpful to provide a new strategy for the dementia caused by Parkinson's disease.

Cordycepin decreases activity of hippocampal CA1 pyramidal neuron through membrane hyperpolarization.

Cordycepin suppresses glutamatergic and GABAergic synaptic transmission through activation of A1 adenosine receptor in rat hippocampal CA1 pyramidal neurons

Cordycepin Suppresses Excitatory Synaptic Transmission in Rat Hippocampal Slices Via a Presynaptic Mechanism

Modulation Effects of Cordycepin on Voltage-Gated Cation Channels on Hippocampal CA1 Pyramidal Neuron

Cordycepin Ameliorates Synaptic Dysfunction and Dendrite Morphology Damage of Hippocampal CA1 Via A1R in Cerebral Ischemia.

Cordycepin Induces Apoptosis in Human Liver Cancer HepG2 Cells Through Extrinsic and Intrinsic Signaling Pathways.

Cordycepin Improves Behavioral‐ltp and Dendritic Structure in Hippocampal CA1 Area of Rats

Neuroprotection of Cordycepin in NMDA-induced Excitotoxicity by Modulating Adenosine A(1) Receptors

Cordycepin ameliorates synaptic dysfunction and dendrite morphology impairments induced by cerebral ischemia via adenosine A1 receptors in vitro and in vivo

Effects of Cordycepin on Spontaneous Alternation Behavior and Adenosine Receptors Expression in Hippocampus.

Neuroprotective effects of cordycepin inhibit glutamate-induced apoptosis in hippocampal neurons

The metaplastic effects of cordycepin in hippocampal CA1 area of rats

Effects of Cordycepin on Y-maze Learning Task in Mice

Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1α through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells.

Cordycepin Improved the Cognitive Function Through Regulating Adenosine A2A Receptors in MPTP Induced Parkinson's Disease Mice Model.

Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer's disease

Cordycepin Modulates Microglial M2 Polarization Coupled with Mitochondrial Metabolic Reprogramming by Targeting HKII and PDK2

Cordycepin generally inhibits growth factor signal transduction in a systems pharmacology study

Cordycepin protects renal ischemia/reperfusion injury through regulating inflammation, apoptosis, and oxidative stress

Promotion of Behavior-Learning and Effect on Number of Hippocampal Neurons of Mice Injured by Ischemia with Cordycepin Treatment

Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway